How Institut Georges Lopez preservation solution protects nonsteatotic and steatotic livers against ischemia-reperfusion injury

Transplantation Proceedings

Volumn 43, Issue 1, 2011, Pages 77-79

  Zaouali, M A ^a,b   Ben Abdennebi, H ^c   Padrissa Altes S ^a   Alfany Fernandez, I ^a   Rimola, A ^b,d   Rosello Catafau J ^a,b,d  

^a INST D INVESTIGACIONS B   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITY OF MONASTIR   (Tunisia)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INSTITUT GEORGES LOPEZ PRESERVATION SOLUTION; NITRIC OXIDE; PRESERVATION SOLUTION; UNCLASSIFIED DRUG;

CELL PROTECTION; CONFERENCE PAPER; DRUG MECHANISM; FATTY LIVER; HUMAN; LIVER GRAFT; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; MITOCHONDRION; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY;

FATTY LIVER; HUMANS; ORGAN PRESERVATION SOLUTIONS; REPERFUSION INJURY;

EID: 79951785523     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.12.026     Document Type: Conference Paper

References (23)

1. Zaouali MA, Ben Adbennebi H, Padrissa-Altés S, et al: Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother 11:537, 2010
2. Casillas-Ramirez A, Ben Mosbah I, Ramalho F, et al: Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. Life Sci 79:1881, 2006
3. Belzer FO, Southard JH: Principles of solid-organ preservation by cold storage. Transplantation 45:673, 1988
4. Selzner M, Clavien PA: Fatty liver in liver transplantation and surgery. Semin Liver Dis 21:105, 2001
5. Imbert CJ, St Peter SD, Handa A, et al: Hepatic steatosis and its relationship to transplantation. Liver Tranpl 8:415, 2002
6. Selzner M, Rudiger HA, Sindram D, et al: Mechanisms of ischemic injury are different in the steatotic and normal rat liver. Hepatology 32:1280, 2000
7. Morariu AM, VD Plaats A, V. Oeveren W, et al: Hyperaggregating effect of hydroxyethyl starch components and University of Wisconsin solution on human red blood cells: a risk of impaired graft perfusion in organ procurement? Transplantation 76:37, 2003
8. Mosbah IB, Franco-Gou R, Abdennebi HB, et al: Effects of polyethylene glycol and hydroxyethyl starch in University of Wisconsin preservation solution on human red blood cell aggregation and viscosity. Transplant Proc 38:1229, 2006
9. Ben Abdennebi H, Ramella-Virieux S, Boillot O, et al: Improved liver preservation: high-K+ UW versus high-Na+ UW. Transplant Proc 29:3541, 1997
10. Badet L, Ben Abdennebi H, Petruzzo P, et al: Effect of IGL-1, a new preservation solution, on kidney grafts (a pre-clinical study). Transpl Int 17:815, 2005
11. Franco-Gou R, Mosbah IB, Serafin A, et al: New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury. J Gastroenterol Hepatol 22:1120, 2007
12. Ben Abdennebi H, Elrassi Z, Scoazec JY, et al: Evaluation of IGL-1 preservation solution using an orthotopic liver transplantation model. World J Gastroenterol 12:5326, 2006
13. Ben Mosbah I, Rosello-catafau J, Franco-Gau R, et al: Preservation of steatotic livers in IGL-1 solution. Liver Transpl 12:1215, 2006
14. Zaouali MA, Ben Mosbah I, Boncompagni E, et al: Hypoxia inducible factor-1alpha accumulation in steatotic liver preservation: role of nitric oxide. World J Gastroenterol 16:3499, 2010
15. Ramalho FS, Fernandez-Monteiro I, Roselló-Catafau J, et al: Hepatic microcirculatory failure. Acta Cir Bras 21:48, 2006
16. Pannen BH, Al-Adili F, Bauer M, et al: Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 27:755, 1998
17. Charrueau CA, Carayon A, Thurman RG: Long-term cold liver storage induces endothelin-1 release and a time-dependent increase in portal pressure at reperfusion in the rat. J Gastroenterol 37:717, 2002
18. Koti RS, Sefailian AM, Mc Bride A, et al: The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver. FASEB J 16:1654, 2002
19. Zaouali MA, Padrissa-Altés S, Ben Mosbah I, et al: Insulin like growth factor-1 increases fatty liver preservation in Igl-1 solution. World J Gastroenterol 16:5693, 2010
20. Wang M, Tsai B, Brown JW, et al: Insulin-like growth factor-1 in myocardial tissue: interaction with tumor necrosis factor. Crit Care 7:417, 2003
21. Peralta C, Hotter G, Closa D, et al: Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: role of nitric oxide and adenosine. Hepatology 25:934, 1997
22. Thomas DD, Ridnour LA, Isenverg JS, et al: The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45:18, 2008
23. Amersi F, Buelow R, Kato H, et al: Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104:1631, 1999